EUVIMEDEUVIMED entdecken
Crossref

Biofilm Control Activity of Triphenylphosphonium‐Conjugated Curcumin Against Staphylococcus aureus

G Kiran Kumar Reddy, Abel Zachariah Babu, Vijay K Kutala, Santosh Kumar Sandur, Y V Nancharaiah iD

APMIS · 2025

DOI: 10.1111/apm.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von G Kiran Kumar Reddy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biofouling and Biofilm Processes Section, Water & Steam Chemistry Division, Bhabha Atomic Research Centre, Kalpakkam, India. Hauptthemen laut MEDLINE: Biofilms, Curcumin, Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Department of Atomic Energy, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hospital‐ and community‐acquired Staphylococcus aureus infections are dominated by their biofilms and cause difficult‐to‐treat persistent infections. As an alternative anti‐biofilm agent, the efficacy of triphenylphosphonium (TPP)‐conjugated curcumin (TPP‐curcumin) was determined against S. aureus biofilms in comparison to that of curcumin and commercial antibiotics. TPP‐curcumin elicited strong anti‐staphylococcal activity with minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of 3.125 and 6.25 μM, respectively. The MIC and MBC values for curcumin and ampicillin were > 125 and > 286.2 μM (100 μg/mL), respectively. The MIC and MBC values were 25.7 μM (12.5 μg/mL) and 103 μM (50 μg/mL), respectively, for kanamycin. TPP‐curcumin was multi‐fold more effective than curcumin in inhibiting biofilm growth. Minimum biofilm inhibitory concentration (MBIC) values of TPP‐curcumin, curcumin, ampicillin and kanamycin were 3.125, > 125, > 286 and 25 μM, respectively. Besides inhibiting biofilm formation, TPP‐curcumin has effectively killed S. aureus cells in pre‐formed or established biofilms. Treatment of biofilms with 25 μM TPP‐curcumin achieved near‐complete cell killing. Exposure to TPP‐curcumin led to severe membrane damage and oxidative stress in S. aureus cells. The strong antimicrobial and antibiofilm activity of TPP‐curcumin suggests its potential use for developing or augmenting antibacterial therapies for drug‐resistant S. aureus infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsCurcuminStaphylococcus aureusAnti-Bacterial AgentsOrganophosphorus CompoundsMicrobial Sensitivity TestsStaphylococcal InfectionsHumans

Stichwörter der Autor:innen

Staphylococcal biofilmsTPP‐curcuminantimicrobial resistancebiofilm preventionmitocurcumin

Substanzen

CurcuminAnti-Bacterial AgentsOrganophosphorus Compoundstriphenylphosphonium

Autor:innen und Institutionen

  • Biofouling and Biofilm Processes Section, Water & Steam Chemistry Division, Bhabha Atomic Research Centre, Kalpakkam, India.
  • Homi Bhabha National Institute, Mumbai, India.
  • Department of Clinical Pharmacology and Therapeutics, Nizam's Institute of Medical Sciences, Hyderabad, India.
  • Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India.

ORCID-Profile: Y V Nancharaiah

Förderung

  • Department of Atomic Energy, Government of India

Zitieren

APA

Reddy, G. K. K., Babu, A. Z., Kutala, V. K., Sandur, S. K., & Nancharaiah, Y. V. (2025). Biofilm Control Activity of Triphenylphosphonium‐Conjugated Curcumin Against Staphylococcus aureus. APMIS. https://doi.org/10.1111/apm.70075

Vancouver

Reddy GKK, Babu AZ, Kutala VK, Sandur SK, Nancharaiah YV. Biofilm Control Activity of Triphenylphosphonium‐Conjugated Curcumin Against Staphylococcus aureus. APMIS. 2025. doi:10.1111/apm.70075

BibTeX
@article{Reddy2025,
  author = {Reddy, G Kiran Kumar and Babu, Abel Zachariah and Kutala, Vijay K and Sandur, Santosh Kumar and Nancharaiah, Y V},
  title = {Biofilm Control Activity of Triphenylphosphonium‐Conjugated Curcumin Against Staphylococcus aureus},
  journal = {APMIS},
  year = {2025},
  doi = {10.1111/apm.70075}
}
Kostenlos starten →